The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer.

Details

Language :

English

ISSN :

1524-4733

Volume :

17

Issue :

7

Database :

MEDLINE

Journal :

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Publication Type :

Academic Journal

Accession number :

27202302

Full Text :

https://doi.org/10.1016/j.jval.2014.08.2321